We are live on ! Find out more
GVI

Green Valley Investors Portfolio holdings

AUM $1.76B
1-Year Est. Return 5.64%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+5.64%
3 Year Est. Return
+59.43%
5 Year Est. Return
+81.11%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
+$216M
Cap. Flow
+$136M
Cap. Flow %
2.63%
Top 10 Hldgs %
63.3%
Holding
27
New
2
Increased
–
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$151M
2
PX
Praxair Inc
PX
+$122M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$110M
2
HSIC icon
Henry Schein
HSIC
+$15.5M
3
IFF icon
International Flavors & Fragrances
IFF
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 56.96%
2 Materials 12.56%
3 Consumer Discretionary 12.13%
4 Communication Services 9.91%
5 Consumer Staples 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$805M 15.49%
9,050,000
– –
CELG
2
DELISTED
Celgene Corp
CELG
$532M 10.25%
4,600,000
– –
JNJ icon
3
Johnson & Johnson
JNJ
$641B
$353M 6.8%
3,625,000
– –
GILD icon
4
Gilead Sciences
GILD
$162B
$351M 6.76%
3,000,000
– –
LKQ icon
5
LKQ Corp
LKQ
$6.69B
$236M 4.54%
7,800,000
– –
WMT icon
6
Walmart Inc
WMT
$889B
$213M 4.1%
9,000,000
– –
SYK icon
7
Stryker
SYK
$129B
$210M 4.05%
2,200,000
– –
TJX icon
8
TJX Companies
TJX
$173B
$199M 3.82%
6,000,000
– –
MAR icon
9
Marriott International
MAR
$101B
$196M 3.77%
2,634,371
– –
DIS icon
10
Walt Disney
DIS
$168B
$194M 3.73%
1,700,000
– –
BHC icon
11
Bausch Health
BHC
$1.67B
$178M 3.42%
800,000
– –
CMCSA icon
12
Comcast
CMCSA
$80.9B
$174M 3.36%
5,800,000
– –
POT
13
DELISTED
Potash Corp Of Saskatchewan
POT
$163M 3.13%
5,250,000
– –
TMO icon
14
Thermo Fisher Scientific
TMO
$208B
$156M 3%
1,200,000
– –
IFF icon
15
International Flavors & Fragrances
IFF
$19.5B
$153M 2.94%
1,400,000
-100,000
-7% -$11.5M
ABT icon
16
Abbott
ABT
$182B
$147M 2.83%
3,000,000
– –
TFCFA
17
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$146M 2.82%
+4,500,000
New +$151M
PX
18
DELISTED
Praxair Inc
PX
$120M 2.3%
+1,000,000
New +$122M
PG icon
19
Procter & Gamble
PG
$346B
$108M 2.08%
1,380,000
– –
HSIC icon
20
Henry Schein
HSIC
$9.64B
$98.1M 1.89%
1,760,367
-279,633
-14% -$15.5M
APD icon
21
Air Products & Chemicals
APD
$65.2B
$82.1M 1.58%
648,600
– –
DD icon
22
DuPont de Nemours
DD
$18.9B
$81.9M 1.58%
631,810
– –
SYY icon
23
Sysco
SYY
$40.2B
$72.2M 1.39%
2,000,000
– –
ABBV icon
24
AbbVie
ABBV
$454B
$67.2M 1.29%
1,000,000
-1,680,000
-63% -$110M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$122B
$61.7M 1.19%
500,000
– –
1
2

Similar funds

GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
BCMNY
Buckingham Capital Management (New York) New York $782M AUM 5.29% 1-Year Est. Return

Green Valley Investors's Q2 2015 Portfolio in Review

As of Q2 2015, Green Valley Investors held 27 positions worth $5.2B, up 4.3% from $4.98B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Green Valley Investors's Q2 2015 filing shows 2 new and 3 reduced positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,500,000 shares worth $146M. The largest sale was AbbVie, an estimated $110M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Materials and Consumer Discretionary.

  • Green Valley Investors's largest Q2 2015 buy was Twenty-First Century Fox, Inc. Class A: 4,500,000 shares worth $146M.
  • Green Valley Investors's biggest Q2 2015 reduction was AbbVie, cutting an estimated $110M.
  • Green Valley Investors's ten largest holdings make up 63% of its $5.2B portfolio in Q2 2015.
  • Green Valley Investors opened 2 new positions and closed 0 in Q2 2015.
  • Green Valley Investors's portfolio value rose 4.3% quarter-over-quarter to $5.2B.

Based on Green Valley Investors's 13F filing for Q2 2015, filed 13 Aug 2015.